On January 3, 2022 Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) reported that it will participate at the H.C. Wainwright BIOCONNECT Virtual Conference taking place January 10-13, 2022 (Press release, Concert Pharmaceuticals, JAN 3, 2022, View Source [SID1234597965]). The on-demand presentation will be available beginning at 7:00 a.m. ET on January 10, 2022.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast of the presentation may be accessed in the Investors section of the Company’s website at www.concertpharma.com. A replay of the conference webcast will be available on Concert’s website for two weeks following the presentation.